A study for a 18 year old boy who takes Vyvanse - from FDA reports


Summary

1,076 males aged 18 (±5) who take the same drug are studied. This is a personalized study for a 18 year old male patient who has Attention Deficit Hyperactivity Disorder (adhd). The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Sep, 12, 2017

1,076 males aged 18 (±5) who take Vyvanse are studied.


Number of reports submitted per year:

Vyvanse for a 18-year old boy.

Information of the patient in this study:

  • Age: 18
  • Gender: male
  • Conditions: Attention Deficit Hyperactivity Disorder (adhd)
  • Drugs taken:
    • Vyvanse (lisdexamfetamine dimesylate)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Memory Loss: 13 (1.21% of males aged 18 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  • insomnia
  • agitation
  • aggression
  • stress and anxiety
  • feeling abnormal
  • dizziness
  • irritability
  • headache
  • drug ineffective
  • heart palpitations
1 - 6 months:
  • drug ineffective
  • anger
  • abnormal behavior
  • drug effect decreased
  • aggression
  • mood swings
  • high blood pressure
  • dizziness
  • convulsion
  • irritability
6 - 12 months:
  • suicidal ideation
  • weight decreased
  • intentional overdose
  • drug ineffective
  • abnormal behavior
  • insomnia
  • aggression
  • drug abuse and dependence
  • psychotic disorder
  • overdose
1 - 2 years:
  • educational problem
  • gait disturbance
  • ventricular extrasystoles
  • stress and anxiety
  • disturbance in attention
  • supraventricular extrasystoles
  • aggression
  • dizziness
  • nausea
  • anorexia
2 - 5 years:
  • convulsion
  • tic
  • drug effect decreased
  • disturbance in attention
  • memory loss
  • stroke
  • upper respiratory tract infection
  • gynaecomastia
  • weight loss
  • impaired work ability
5 - 10 years:
  • appetite - decreased
  • educational problem
  • sedation
10+ years:
n/a
not specified:
  • drug ineffective
  • stress and anxiety
  • aggression
  • insomnia
  • headache
  • appetite - decreased
  • drug effect decreased
  • disturbance in attention
  • agitation
  • suicidal ideation

Top conditions involved for these people *:

  • Narcolepsy (27 people, 2.51%)
  • Bipolar Disorder (19 people, 1.77%)
  • Stress And Anxiety (18 people, 1.67%)
  • Insomnia (16 people, 1.49%)
  • Acne (16 people, 1.49%)

Top co-used drugs for these people *:

  • Abilify (41 people, 3.81%)
  • Clonidine (34 people, 3.16%)
  • Zoloft (33 people, 3.07%)
  • Xyrem (31 people, 2.88%)
  • Strattera (30 people, 2.79%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Memory loss, Attention deficit hyperactivity disorder (adhd), Vyvanse

You may be interested in these reviews

More reviews for: Memory loss, Attention deficit hyperactivity disorder (adhd), Vyvanse